Bipartisan Lawmakers Urge CMS to Crack Down on Medicare Advantage Overpayments

Bipartisan lawmakers are pushing the Centers for Medicare and Medicaid Services to intensify enforcement against Medicare Advantage overpayments in 2026, targeting billing practices that have inflated federal spending on the program for years [1]. The timing matters: as regulatory scrutiny tightens on MA plans, marketing leaders face a dual mandate—maintain enrollment growth while navigating heightened compliance risk that could reshape how plans communicate their value proposition to seniors.

The pressure comes as Medicare Advantage enrollment surpasses 33 million beneficiaries, representing more than half of all Medicare-eligible Americans. The program's growth has made it a budget target, with congressional watchdogs identifying billions in improper payments stemming from diagnosis coding practices that inflate risk scores without corresponding patient care. For health plans, this creates immediate marketing implications: acquisition costs are rising as competition intensifies, while regulatory uncertainty makes long-term member value calculations increasingly complex.

Marketing leaders at MA plans now operate in a environment where clinical documentation, coding accuracy, and member engagement strategies converge. The plans that built enrollment through aggressive risk adjustment strategies face different marketing challenges than those emphasizing preventive care and member experience. "This approval demonstrates what the FDA can achieve when we eliminate delays and prioritize fast and thorough work," said FDA Commissioner Martin Makary, M.D., M.P.H., in announcing the fastest new drug approval since 2002 under the National Priority Voucher program [2]. While his comment addressed pharmaceutical review timelines, the principle applies: regulators across healthcare are signaling that speed cannot compromise integrity.

The overpayment controversy matters beyond MA plans. For healthcare marketers across sectors, it demonstrates how payment integrity issues become brand reputation issues. When CMS pursues overpayment recovery, plans face not just financial penalties but member trust erosion—and in a market where beneficiaries can switch plans annually during open enrollment, reputation damage translates directly to member churn. The regulatory environment also affects partnership strategies: providers, pharmacy benefit managers, and digital health vendors aligned with scrutinized plans must reconsider their own compliance postures and marketing claims.

The Risk Adjustment Reality: When Marketing Meets Coding

Medicare Advantage plans receive higher payments for sicker beneficiaries through the risk adjustment model, creating financial incentives to document every diagnosis thoroughly. The system's intent—ensuring plans aren't penalized for enrolling complex patients—is sound. The execution has drawn bipartisan criticism.

Plans invested heavily in home health assessments, chart reviews, and supplemental diagnosis coding programs to capture undocumented conditions. These programs generated clinical data that supported higher risk scores and federal payments. Lawmakers now characterize some of these practices as "upcoding"—documenting diagnoses that don't reflect active treatment or meaningful clinical care.

For marketing teams, this creates a content strategy dilemma. Many MA plans marketed their comprehensive assessment programs as member benefits—"We'll send a nurse to your home at no cost." These programs served dual purposes: member engagement and revenue optimization. As regulatory scrutiny intensifies, plans must evaluate whether these marketing messages withstand compliance review.

The financial stakes are substantial. CMS pays MA plans approximately $12,000 per member annually on average, with significant variation based on geographic location and risk scores. A one-point increase in average risk score across a 100,000-member plan translates to roughly $20 million in additional annual revenue. Plans that built enrollment projections on aggressive risk adjustment face potential payment reductions that directly impact marketing budgets.

Brand Positioning in a Compliance-First Environment

Health plans historically differentiated on benefits: zero-dollar premiums, comprehensive dental coverage, gym memberships. As benefit parity increases—most plans now offer similar supplemental benefits—marketing leaders sought differentiation through member experience narratives and clinical program messaging.

The overpayment controversy forces a positioning recalibration. Plans must demonstrate value without overpromising clinical outcomes or implying inappropriate financial motivations. Marketing claims about "comprehensive care management" or "personalized health assessments" require legal review to ensure they don't suggest coding-driven rather than care-driven programs.

This parallels challenges in pharmaceutical marketing. When the FDA approved Foundayo (orforglipron), the first new molecular entity under the National Priority Voucher program, in just 50 days—294 days ahead of the standard timeline—it demonstrated regulatory efficiency without compromising safety standards [2]. The GLP-1 receptor agonist for obesity management entered a crowded market where competitor marketing claims face intense FTC scrutiny. MA plans face similar dynamics: intense competition in a space where regulators are simultaneously accelerating some processes (prior authorization reforms) while tightening others (payment integrity).

Plans that positioned themselves as "disruptors" or "innovative alternatives" to traditional Medicare now risk association with regulatory non-compliance. Conservative positioning—emphasizing care coordination, member service quality, and transparent partnerships with providers—becomes strategically safer.

Member Communication During Regulatory Uncertainty

Open enrollment represents a $4 billion annual marketing window for MA plans, with member acquisition costs ranging from $500 to $1,200 depending on geography and competition intensity. Plans typically recover acquisition costs over 18 to 24 months through favorable medical loss ratios and retention.

Regulatory uncertainty disrupts this calculus. If CMS implements stricter risk adjustment audits or changes payment methodology, plans may see revenue reductions of 5% to 8% for affected members. This compresses margins and extends payback periods, making member lifetime value calculations less reliable.

Marketing leaders must adapt messaging to maintain enrollment while preparing for potential payment reductions. This requires:

Shifting value propositions from benefits breadth to care quality. Rather than leading with “20 additional benefits,” emphasize clinical outcomes, member satisfaction scores, and provider network strength.

Transparency about coding practices. Proactive communication about why the plan conducts health assessments builds trust. Frame these as genuine clinical tools rather than administrative requirements.

Provider partnership emphasis. Members trust their physicians. Plans that demonstrate strong provider relationships and care coordination—rather than administrative burden—differentiate more effectively in a compliance-conscious environment.

Digital engagement strategies that document value. Telehealth utilization, medication adherence tracking, and preventive care completion rates provide concrete evidence of member engagement beyond coding intensity.

Compliance as Competitive Advantage

Forward-thinking plans are reframing compliance investment as brand differentiation. This mirrors pharmaceutical companies' approach to adverse event reporting and clinical trial transparency—areas where regulatory requirements become marketing proof points.

Marketing claims supported by defensible data withstand regulatory scrutiny and competitor challenges. Plans can substantiate "comprehensive care" claims by showing utilization of preventive services, not just diagnostic codes. Quality Star Ratings, already a CMS-mandated transparency tool, become more valuable as marketing assets when payment integrity is questioned.

Plans should audit existing marketing materials for vulnerability:

• Remove claims that imply financial motivations for clinical programs
• Emphasize member-reported outcomes over process metrics
• Document how supplemental benefits drive engagement, not just enrollment
• Ensure sales materials don't incentivize inappropriate coding discussions with members

The 1ness Take

The Medicare Advantage overpayment scrutiny presents a disguised opportunity for marketing leaders willing to lead with compliance rather than react to enforcement.

Here's the strategic shift: treat payment integrity as a brand pillar, not a legal obligation. The plans that will dominate the next enrollment cycle aren't those with the most benefits or the lowest premiums—those are table stakes in a mature market. Winners will be plans that credibly demonstrate they optimize outcomes, not revenue codes.

This requires marketing and compliance integration that most health plans haven't achieved. Compliance officers typically review marketing materials for regulatory violations. Reverse that relationship: let compliance data inform marketing strategy. If your plan's risk scores increase because you're genuinely managing complex populations better—demonstrated through care plan completion rates, specialist referral appropriateness, or medication optimization—that's a marketing story with regulatory insulation.

Consider the FDA's National Priority Voucher program: 50-day approval for a new obesity drug in a therapeutic category drowning in competition [2]. Speed mattered, but safety mattered more. The agency didn't compromise standards to move fast; it eliminated delays. Apply this to MA marketing: don't compromise compliance to win enrollment; eliminate the false choice between growth and integrity.

Practically, this means building marketing campaigns around transparent metrics. Member Net Promoter Scores. HEDIS quality measures. Provider satisfaction with your utilization management processes. Stars Rating trajectories. These metrics serve dual purposes: they satisfy CMS requirements and differentiate your plan to increasingly sophisticated Medicare beneficiaries who understand that their plan's regulatory standing affects long-term stability.

The plans treating this as a crisis—pulling back on assessment programs, reducing marketing spend, defensive positioning—are missing the moment. The plans that lean in with transparent, data-driven value propositions will capture market share from competitors paralyzed by uncertainty.

One tactical recommendation: create a "Payment Integrity Dashboard" as a member-facing tool. Show how your risk adjustment practices align with clinical care delivery. This seems counterintuitive—why draw attention to a controversial area? Because transparency demonstrates confidence. Members don't understand risk adjustment methodology, but they understand that plans willing to explain their financial model aren't hiding problems.

The Takeaway

Medicare Advantage marketing leaders face a strategic inflection point in 2026. The bipartisan push for overpayment enforcement isn't temporary political theater—it reflects structural tension in how MA plans are paid and how that payment methodology influences clinical and marketing decisions.

Immediate actions for marketing leaders:

Audit all member-facing materials for language suggesting financial motivations for clinical programs. Replace “comprehensive assessments capture all your conditions” with “personalized care plans address your specific health needs.”

Quantify member engagement beyond coding. Track and market preventive care completion rates, chronic condition management participation, and member-reported health improvements. These metrics demonstrate genuine care delivery.

Prepare for open enrollment volatility. Build scenario models for acquisition cost changes if regulatory uncertainty increases member shopping behavior. Diversify marketing spend to emphasize retention and member satisfaction, not just new enrollment.

The Medicare Advantage market isn't contracting—it's maturing. Marketing strategies that worked in a high-growth, lower-scrutiny environment require evolution. Plans that integrate compliance strength into brand identity will command premium positioning as regulatory pressure separates sophisticated operators from opportunistic players.